Home › Kanser sa Baga › Virginia › Arlington
Pag-aaral pangklinika para sa Kanser sa Baga sa Arlington, VA
Isang pag-aaral para sa Kanser sa Baga ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Arlington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi ang layo
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Nagre-recruitPhase 2
- Virginia Cancer Specialists (VCS) ( Site 0408), Fairfax · 11 mi ang layo
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Nagre-recruitPhase 3
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Nagre-recruitPhase 3
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
A Study of PHN-012 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1
- PHN-012-001 Site, Fairfax · 11 mi ang layo
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Inova Schar Cancer Infusion Pharmacy, Fairfax · 11 mi ang layo
- Inova Schar Cancer, Fairfax · 11 mi ang layo
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Nagre-recruitPhase 2
- Research Site, Fairfax · 11 mi ang layo
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Nagre-recruitPhase 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Nagre-recruitPhase 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 mi ang layo
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Nagre-recruitPhase 1
- NEXT - Virginia, Fairfax · 11 mi ang layo
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Nagre-recruitPhase 3
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Nagre-recruitPhase 1/2
- NEXT Virginia, Fairfax · 11 mi ang layo
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Nagre-recruitPhase 1
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- USO - Virginia Cancer Specialists, Fairfax · 11 mi ang layo
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi ang layo
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Nagre-recruitPhase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi ang layo
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Nagre-recruitPhase 1
- NEXT Oncology, Fairfax · 11 mi ang layo
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
- Inova Fair Oaks Hospital, Fairfax · 11 mi ang layo
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Nagre-recruitPhase 3
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Nagre-recruitPhase 3
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Nagre-recruitPhase 3
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
- Inova Fair Oaks Hospital, Fairfax · 11 mi ang layo
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi ang layo
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Nagre-recruitPhase 1/2
- NEXT Virginia, Fairfax · 11 mi ang layo
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Nagre-recruitPhase 1
- NEXT Virginia, Fairfax · 11 mi ang layo
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Nagre-recruitPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Nagre-recruitPhase 1
- NEXT Virginia, Fairfax · 11 mi ang layo
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Nagre-recruitPhase 1
- Research Site, Fairfax · 11 mi ang layo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi ang layo
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
- NEXT Virginia, Fairfax · 11 mi ang layo
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Nagre-recruitPhase 1/2
- Next Oncology Virginia, Fairfax · 11 mi ang layo
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Nagre-recruitPhase 1/2
- NEXT Oncology, Fairfax · 11 mi ang layo
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi ang layo
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi ang layo
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Nagre-recruitPhase 2
- Inova Fairfax Hospital, Fairfax · 11 mi ang layo
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Nagre-recruitPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Nagre-recruitPhase 1/2
- NEXT Virginia, Fairfax · 11 mi ang layo
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- NEXT Virginia, Fairfax · 11 mi ang layo
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Nagre-recruitPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Pag-aaral para sa Kanser sa Baga sa ibang lungsod
- Houston, TX78 pag-aaral
- Boston, MA62 pag-aaral
- New York City, NY60 pag-aaral
- Los Angeles, CA45 pag-aaral
- Washington, DC41 pag-aaral
- Chicago, IL41 pag-aaral
- Nashville, TN40 pag-aaral
- Baltimore, MD40 pag-aaral
- St. Louis, MO39 pag-aaral
- Columbus, OH37 pag-aaral
- Philadelphia, PA36 pag-aaral
- Seattle, WA33 pag-aaral
Iba pang pag-aaral sa Arlington
- Non-Small Cell Lung Cancer104 pag-aaral
- Metastatic Cancer53 pag-aaral
- Colorectal Cancer52 pag-aaral
- Kanser (lahat ng uri)48 pag-aaral
- Kanser sa Suso46 pag-aaral
- Kanser sa Ovary46 pag-aaral
- Kanser ng Endometrium39 pag-aaral
- Kanser sa Pancreas33 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg26 pag-aaral
- Small Cell Lung Cancer23 pag-aaral
- Triple-Negative Breast Cancer20 pag-aaral
- Kanser sa Tiyan20 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.